© 2020 – 2024 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
Image default
News

Pfizer vaccine second dose has ‘sweet spot’ after eight weeks, UK scientists say

Longer schedule led to more Covid antibodies and higher proportion of helper T-cells, supporting immune memory – researchers

  • See all our coronavirus coverage

An eight-week gap between the first and second doses of the Pfizer/BioNTech Covid-19 vaccine is a “sweet spot” when it comes to generating strong immune response while protecting the UK population against the Delta variant of coronavirus, scientists have said.

In a study funded by the Department of Health and Social Care (DHSC), researchers have found that when compared with a four-week gap, a 10-week interval between the doses produces higher antibody levels, as well as a higher proportion of a group of infection-fighting cells in the body known as “helper” T-cells.

Continue reading…

Related posts

Priti Patel to meet French minister over migrant crossings

AEA3

Luciana Berger rejoins Labour after Keir Starmer’s antisemitism apology

AEA3

Soaring prices push 1.6m more UK households into financial trouble – study

AEA3